Document Type

Article

Publication Date

7-27-2021

Publication Title

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

First page number:

1

Last page number:

3

Abstract

Aducanumab recently received accelerated approval by the FDA. An Expert Panel was comprised to provide recommendations on appropriate use of aducanumab in real world practices. Patient selection, aducanumab administration and monitoring, management of ARIA, and best practices in patient care in the context of aducanumab therapy are described. The paper was published in the Journal of Prevention of Alzheimer's Disease.

Keywords

Aducanumab; Aduhelm; Alzheimer’s disease; Amyloid imaging; Appropriate use; Aria; MRI; Titration

Disciplines

Cognitive Neuroscience

File Format

pdf

File Size

96 KB

Language

English

Rights

IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Download

UNLV article access

Search your library

Share

COinS